To close out this 3-part series, Terri Conneran, founder of KRAS (Knowledge + Research + Advocacy = Survivorship) Kickers, Jennifer Aversano, MSN, RN, OCN, ONN-CG, a lung nurse navigator at Northwest Community Hospital, and Claudia Miller, RN, ONC, ONN-CG, a thoracic oncology nurse navigator at Hollings Cancer Center, will explore the CEACAM 5 biomarker, clinical trial recruitment strategies deployed by navigators, and the role that shared decision-making has on patient outcomes throughout their treatment. 

Thank you to our sponsor, Sanofi, for making this biomarker podcast series possible.